Endoscopic ultrasound-guided liver biopsy

Parth J Parekh, Raj Majithia, David L Diehl, Todd H Baron, Parth J Parekh, Raj Majithia, David L Diehl, Todd H Baron

Abstract

Liver biopsy remains the cornerstone in the diagnosis and management of liver disorders. Results of liver biopsy can often drive therapeutic decision-making. Unfortunately, studies have shown conventional biopsy techniques to carry significant sampling variability that can potentially impact patient care. Endoscopic ultrasound (EUS) is gaining traction as an alternative method of biopsy. For parenchymal disease, it can decrease sampling variability. It offers a more targeted approach for focal lesions. Its diagnostic yield and limited adverse event profile make it a promising approach for liver biopsy.

Keywords: EUS-guided liver biopsy (EUS-LB); Endoscopic ultrasound (EUS); Tru-Cut biopsy; fine needle biopsy; liver biopsy; nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH).

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol. 2001;35:195–9.
    1. Sorbi D, Mcgill DB, Thistle JL, et al. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol. 2000;95:3206–10.
    1. Gor N, Salem SB, Jakate S, et al. Histological adequacy of EUS-guided liver biopsy when using a 19-gauge non-Tru-Cut FNA needle. Gastrointest Endosc. 2014;79:170–2.
    1. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614–8.
    1. Denzer U, Arnoldy A, Kanzler S, et al. Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: Diagnosis of cirrhosis and complications. J Clin Gastroenterol. 2007;41:103–10.
    1. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med. 1979;139:667–9.
    1. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut. 1999;Suppl 4:IV1–11.
    1. Rösch J, Lakin PC, Antonovic R, et al. Transjugular approach to liver biopsy and transhepatic cholangiography. N Engl J Med. 1973;289:227–31.
    1. Eisenberg E, Konopniki M, Veitsman E, et al. Prevalence and characteristics of pain induced by percutaneous liver biopsy. Anesth Analg. 2003;96:1392–6. table of contents.
    1. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med. 1993;118:96–8.
    1. Perrault J, Mcgill DB, Ott BJ, et al. Liver biopsy: Complications in 1000 inpatients and outpatients. Gastroenterology. 1978;74:103–6.
    1. McGill DB, Rakela J, Zinsmeister AR, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99:1396–400.
    1. Veneri RJ, Gordon SC, Fink-Bennett D. Scintigraphic and culdoscopic diagnosis of bile peritonitis complicating liver biopsy. J Clin Gastroenterol. 1989;11:571–3.
    1. Chahal PS, Ready J. Hemothorax after percutaneous liver biopsy: An unusual complication. Am J Gastroenterol. 2002;97:1068–9.
    1. Sheth D, Pillai A, Ferral H, et al. Transient bacteremia after a percutaneous liver biopsy. J Vasc Interv Radiol. 2009;20:1429–30.
    1. Scheele J, Altendorf-Hofmann A. Tumor implantation from needle biopsy of hepatic metastases. Hepatogastroenterology. 1990;37:335–7.
    1. Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2:165–73.
    1. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: How safe is it? Ann Intern Med. 1993;118:150–3.
    1. West J, Card TR. Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology. 2010;139:1230–7.
    1. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int. 2008;28:705–12.
    1. Ratziu V, Charlotte F, Heurtier A, et al. LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898–906.
    1. Vuppalanchi R, Unalp A, Van Natta ML, et al. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:481–6.
    1. Larson SP, Bowers SP, Palekar NA, et al. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Clin Gastroenterol Hepatol. 2007;5:1329–32.
    1. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–57.
    1. Rockey DC, Caldwell SH, Goodman ZD, et al. American Association for the Study of Liver Diseases. Liver biopsy. Hepatology. 2009;49:1017–44.
    1. Kalambokis G, Manousou P, Vibhakorn S, et al. Transjugular liver biopsy – indications, adequacy, quality of specimens, and complications - a systematic review. J Hepatol. 2007;47:284–94.
    1. Behrens G, Ferral H. Transjugular liver biopsy. Semin Intervent Radiol. 2012;29:111–7.
    1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500.
    1. Mandelstam P, Plumlee J. Percutaneous liver biopsy in the uncooperative adult. J Clin Gastroenterol. 1987;9:716–7.
    1. Mammen T, Keshava SN, Eapen CE, et al. Transjugular liver biopsy: A retrospective analysis of 601 cases. J Vasc Interv Radiol. 2008;19:351–8.
    1. Wiersema MJ, Levy MJ, Harewood GC, et al. Initial experience with EUS-guided trucut needle biopsies of perigastric organs. Gastrointest Endosc. 2002;56:275–8.
    1. Dewitt J, McGreevy K, Cummings O, et al. Initial experience with EUS-guided Tru-cut biopsy of benign liver disease. Gastrointest Endosc. 2009;69:535–42.
    1. Gleeson FC, Clayton AC, Zhang L, et al. Adequacy of endoscopic ultrasound core needle biopsy specimen of nonmalignant hepatic parenchymal disease. Clin Gastroenterol Hepatol. 2008;6:1437–40.
    1. Mathew A. EUS-guided routine liver biopsy in selected patients. Am J Gastroenterol. 2007;102:2354–5.
    1. Stavropoulos SN, Im GY, Jlayer Z, et al. High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction. Gastrointest Endosc. 2012;75:310–8.
    1. Diehl DL, Johal AS, Khara HS, et al. Endoscopic ultrasound-guided liver biopsy: A multicenter experience. Endoscopy International Online. 2015;3:e1–6.
    1. Hein E, Albrecht A, Melzer D, et al. Computer-assisted diagnosis of focal liver lesions on CT images evaluation of the Perceptron algorithm. Acad Radiol. 2005;12:1205–10.
    1. Namasivayam S, Martin DR, Saini S. Imaging of liver metastases: MRI. Cancer Imaging. 2007;7:2–9.
    1. Martie A, Sporea I, Popescu A, et al. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma. Med Ultrason. 2011;13:108–13.
    1. Awad SS, Fagan S, Abudayyeh S, et al. Preoperative evaluation of hepatic lesions for the staging of hepatocellular and metastatic liver carcinoma using endoscopic ultrasonography. Am J Surg. 2002;184:601–5.
    1. Goletti O, Chiarugi M, Buccianti P, et al. Subcutaneous implantation of liver metastasis after fine needle biopsy. Eur J Surg Oncol. 1992;18:636–7.
    1. Andersson R, Andrén-sandberg A, Lundstedt C, et al. Implantation metastases from gastrointestinal cancer after percutaneous puncture or biliary drainage. Eur J Surg. 1996;162:551–4.
    1. Bhatia V, Hijioka S, Hara K, et al. Endoscopic ultrasound description of liver segmentation and anatomy. Dig Endosc. 2014;26:482–90.
    1. Nguyen P, Feng JC, Chang KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc. 1999;50:357–61.
    1. tenBerge J, Hoffman BJ, Hawes RH, et al. EUS-guided fine needle aspiration of the liver: Indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc. 2002;55:859–62.
    1. DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: A large single-center experience. Am J Gastroenterol. 2003;98:1976–81.
    1. Singh P, Mukhopadhyay P, Bhatt B, et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: Results of a prospective comparative study. J Clin Gastroenterol. 2009;43:367–73.
    1. de Oliveria Andrade LJ, d’Oliveira A, Melo RC, et al. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis. 2009;1:33–7.
    1. Kida A, Matsuda K, Hirai S, et al. A case of hepatocellular carcinoma showed the usefulness of endoscopic ultrasound-guided fine needle aspiration cytology using the cell block technique for differential diagnosis of gastric submucosal tumor. Nihon Shokakibyo Gakkai Zasshi. 2012;109:952–60.
    1. Kimura H, Matsubayashi H, Fukutomi A, et al. Lymph node metastasis diagnosed by EUS-FNA in four cases with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2011;35:237–40.
    1. Storch I, Gomez C, Contreras F, et al. Hepatocellular carcinoma (HCC) with portal vein invasion, masquerading as pancreatic mass, diagnosed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) Dig Dis Sci. 2007;52:789–91.
    1. Hollerbach S, Reiser M, Topalidis T, et al. Diagnosis of hepatocellular carcinoma (HCC) in a high-risk patient by using transgastric EUS-guided fine-needle biopsy (EUS-FNA) Z Gastroenterol. 2003;41:995–8.
    1. Singh P, Erickson RA, Mukhopadhyay P, et al. EUS for detection of the hepatocellular carcinoma: Results of a prospective study. Gastrointest Endosc. 2007;66:265–73.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅